|
Updated analysis of a phase I/II study of venetoclax in combination with daratumumab and dexamethasone, +/- bortezomib, in patients with relapsed/refractory multiple myeloma. |
|
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda; Tecnofarma; TG Therapeutics |
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Fortis (Inst); Janssen (Inst); Merck (Inst); Sutro Biopharma (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda |
|
|
Consulting or Advisory Role - Celgene; Karyopharm Therapeutics |
Research Funding - Abbvie (Inst); Celgene (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst); Signal Genetics (Inst); Takeda (Inst) |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen; Novartis; Takeda |
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Cilag; GlaxoSmithKline; Janssen; Takeda |
Research Funding - Abbvie; Amgen; Celgene; Cilag; GlaxoSmithKline; Janssen; Takeda |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Celgene |
|
|
Honoraria - Celgene; Janssen |
Consulting or Advisory Role - Oncopeptides; Sanofi; Takeda |
|
|
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Takeda |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
Travel, Accommodations, Expenses - Abbvie |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda |
Research Funding - Celgene (Inst); Janssen (Inst) |